OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical and translational attributes of immune-related adverse events
Karijn P.M. Suijkerbuijk, Mick J M van Eijs, Femke van Wijk, et al.
Nature Cancer (2024) Vol. 5, Iss. 4, pp. 557-571
Closed Access | Times Cited: 33
Karijn P.M. Suijkerbuijk, Mick J M van Eijs, Femke van Wijk, et al.
Nature Cancer (2024) Vol. 5, Iss. 4, pp. 557-571
Closed Access | Times Cited: 33
Showing 26-50 of 33 citing articles:
A Novel Dataset for Nuclei and Tissue Segmentation in Melanoma with baseline nuclei segmentation and tissue segmentation benchmarks
Mark Schuiveling, Hong Liu, Daniel Eek, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Mark Schuiveling, Hong Liu, Daniel Eek, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Metal‐organic frameworks‐based nanomedicines to promote cancer immunotherapy: Recent advances and future directions
Chenqian Feng, Xiaoyan Liang, Rangrang Fan, et al.
MedComm – Biomaterials and Applications (2024) Vol. 3, Iss. 4
Open Access
Chenqian Feng, Xiaoyan Liang, Rangrang Fan, et al.
MedComm – Biomaterials and Applications (2024) Vol. 3, Iss. 4
Open Access
Targeting IL‐17A to manage immunotherapy‐induced toxicity in melanoma
Kai Huang
Cancer Communications (2024)
Open Access
Kai Huang
Cancer Communications (2024)
Open Access
Niacin-Cholic Acid-Peptide Conjugate Act as a Potential Antibiotic Adjuvant to Mitigate Polymicrobial Infections Caused by Gram-Negative Pathogens
Sayed M. Safwan, Devashish Mehta, Amit Arora, et al.
ACS Infectious Diseases (2024)
Closed Access
Sayed M. Safwan, Devashish Mehta, Amit Arora, et al.
ACS Infectious Diseases (2024)
Closed Access
It Takes a Village! Navigating the Challenges and Opportunities in Immune-Related Adverse Event Management
Maysa Vilbert, Leyre Zubiri, Meghan J. Mooradian, et al.
JCO Oncology Practice (2024)
Closed Access
Maysa Vilbert, Leyre Zubiri, Meghan J. Mooradian, et al.
JCO Oncology Practice (2024)
Closed Access
Engineered CARD11–PIK3R3 T‐cell therapies as weapons of cancer mass destruction
Wanlu Zhang, Min Wu, Yongye Huang
MedComm (2024) Vol. 5, Iss. 7
Open Access
Wanlu Zhang, Min Wu, Yongye Huang
MedComm (2024) Vol. 5, Iss. 7
Open Access
Updates and emerging trends in the management of immune-related adverse events associated with immune checkpoint inhibitor therapy
Ninh M. La‐Beck, Jesuwapelumi Owoso
Asia-Pacific Journal of Oncology Nursing (2024) Vol. 11, Iss. 9, pp. 100549-100549
Open Access
Ninh M. La‐Beck, Jesuwapelumi Owoso
Asia-Pacific Journal of Oncology Nursing (2024) Vol. 11, Iss. 9, pp. 100549-100549
Open Access
Neutrophil-to-lymphocyte ratio as a predictive biomarker for hyperprogressive disease mediated by immune checkpoint inhibitors: a systematic review and meta-analysis
Bo Pei, Jue Zhang, Lin Lai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Bo Pei, Jue Zhang, Lin Lai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Simple theranostics nanoagent for precision suppression of tumor growth and Metastasis: A traditional fermented product having a novel functional breakthrough
Pengmin Liu, Rong Dai, Juan Li, et al.
Chemical Engineering Journal (2024) Vol. 500, pp. 156545-156545
Closed Access
Pengmin Liu, Rong Dai, Juan Li, et al.
Chemical Engineering Journal (2024) Vol. 500, pp. 156545-156545
Closed Access
Biomarkers in the early stage of PD-1 inhibitor treatment have shown superior predictive capabilities for immune-related thyroid dysfunction
Jinyu Liu, Mengli Chen, Shu Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Jinyu Liu, Mengli Chen, Shu Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
